Italia markets close in 4 hours 45 minutes

Sinopharm Group Co. Ltd. (SHTDF)

Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,44000,0000 (0,00%)
Alla chiusura: 12:49PM EST

Sinopharm Group Co. Ltd.

Sinopharm Group Building
No. 385, East Longhua Road Huangpu District
Shanghai 200023
China

https://www.sinopharmgroup.com.cn

Settore/iHealthcare
SettoreMedical Distribution
Impiegati a tempo pieno113.234

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Qingming YuExec. Chairman981,88kN/D1964
Mr. Yong LiuPres & Exec. Director980,56kN/D1969
Ms. Xiaojuan LiChief Financial OfficerN/DN/D1976
Mr. Yijian WuSec. to the Board, Company Sec. & Authorised RepresentativeN/DN/D1970
Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Governance aziendale

L'ISS Governance QualityScore di Sinopharm Group Co. Ltd. al 1 gennaio 2023 è 10. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 10; diritti degli azionisti: 8; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.